ZCL Chemicals Ltd

zclchemicals.com

We (formerly Zandu Chemicals Ltd) are one of the fastest growing Pharmaceutical companies in India that combines the power of Science & Technology together. Established in 1991, we are headquartered in Mumbai and have a state-of- the- art US FDA successfully inspected facility with a capacity of 214 KL along with strong research & development capabilities strategically located in the industrial park of Ankleshwar, Gujarat.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

BUSHU PHARMA'S PARTNERSHIP WITH SUZUKEN GROUP INCREASES SPECIALTY PHARMACEUTICAL SERVICES

Bushu Pharmaceuticals Ltd. | April 28, 2021

news image

Bushu Pharmaceuticals Ltd. has entered into a business partnership arrangement with Suzuken Co., Ltd. to provide specialty pharmaceutical producers looking to enter the Japanese market with extensive support for new product releases. In recent years, the market has seen an increase in the number of innovative specialty pharmaceuticals, such as biopharmaceuticals, regenerative medicines, and orphan drugs for rare diseases, that require strict temperature, inventory, and security co...

Read More

Business Insights

MILLIPORESIGMA INVESTS $ 286 MILLION IN U.S. DRUG SAFETY TESTING CAPACITY

MilliporeSigma | November 16, 2022

news image

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that its Life Science business sector is investing more than $ 286 million in its biosafety testing capacity at the company's site in Rockville, Maryland, USA. This will significantly increase the company's ability to conduct biosafety testing and analytical development services. Biosafety testing and analytical development are critical and fund...

Read More

Pharma Tech

ANGELINI PHARMA SELECTS AIDEA’S ARTIFICIAL INTELLIGENCE TO BOOST ITS GROWTH

Angelini Pharma | March 11, 2021

news image

Trueblue, a main supplier of AI answers for Operational and Analytical CRM in the Life Science industry reports that Angelini Pharma, as a feature of a significant global computerized change measure, has picked AiDEA, the principal AI-Digital Cloud Pharma CRM arrangement dependent on Microsoft Dynamics 365. Angelini Pharma is a main pharmaceutical organization focused on aiding patients in the remedial zones of Central Nervous System (CNS) and Mental Health (including Pain), Rare Diseases and Co...

Read More

Research

THERMO FISHER SKETCHES OUT CARLSBAD PLASMID DNA PLANT AS GERMAN CELL AND GENE THERAPY FACILITY PREPS FOR OPENING

Thermo Fisher | December 23, 2020

news image

Thermo Fisher Scientific is shoring up production of cell and quality treatments on the two sides of the lake, a move it expectations will support the advancement of COVID-19 medications and antibodies—and guarantee supplies are set up should they get by with controllers. The New Jersey contract producer is spreading out another plasmid DNA fabricating office at its Carlsbad, California, grounds, intending to help its phone and quality treatment contributions against the set...

Read More
news image

Pharmacy Market

BUSHU PHARMA'S PARTNERSHIP WITH SUZUKEN GROUP INCREASES SPECIALTY PHARMACEUTICAL SERVICES

Bushu Pharmaceuticals Ltd. | April 28, 2021

Bushu Pharmaceuticals Ltd. has entered into a business partnership arrangement with Suzuken Co., Ltd. to provide specialty pharmaceutical producers looking to enter the Japanese market with extensive support for new product releases. In recent years, the market has seen an increase in the number of innovative specialty pharmaceuticals, such as biopharmaceuticals, regenerative medicines, and orphan drugs for rare diseases, that require strict temperature, inventory, and security co...

Read More
news image

Business Insights

MILLIPORESIGMA INVESTS $ 286 MILLION IN U.S. DRUG SAFETY TESTING CAPACITY

MilliporeSigma | November 16, 2022

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that its Life Science business sector is investing more than $ 286 million in its biosafety testing capacity at the company's site in Rockville, Maryland, USA. This will significantly increase the company's ability to conduct biosafety testing and analytical development services. Biosafety testing and analytical development are critical and fund...

Read More
news image

Pharma Tech

ANGELINI PHARMA SELECTS AIDEA’S ARTIFICIAL INTELLIGENCE TO BOOST ITS GROWTH

Angelini Pharma | March 11, 2021

Trueblue, a main supplier of AI answers for Operational and Analytical CRM in the Life Science industry reports that Angelini Pharma, as a feature of a significant global computerized change measure, has picked AiDEA, the principal AI-Digital Cloud Pharma CRM arrangement dependent on Microsoft Dynamics 365. Angelini Pharma is a main pharmaceutical organization focused on aiding patients in the remedial zones of Central Nervous System (CNS) and Mental Health (including Pain), Rare Diseases and Co...

Read More
news image

Research

THERMO FISHER SKETCHES OUT CARLSBAD PLASMID DNA PLANT AS GERMAN CELL AND GENE THERAPY FACILITY PREPS FOR OPENING

Thermo Fisher | December 23, 2020

Thermo Fisher Scientific is shoring up production of cell and quality treatments on the two sides of the lake, a move it expectations will support the advancement of COVID-19 medications and antibodies—and guarantee supplies are set up should they get by with controllers. The New Jersey contract producer is spreading out another plasmid DNA fabricating office at its Carlsbad, California, grounds, intending to help its phone and quality treatment contributions against the set...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us